Laboratory Turnaround Time (TAT): The Complete Guide to Measuring and Improving It

What Is Laboratory Turnaround Time?

Laboratory turnaround time refers to the time elapsed between a defined start event and a defined end event in the laboratory testing process. In most contexts, this means the interval from when a sample is received at the laboratory to when a validated result is available to the requesting clinician.

The clinical stakes are significant. For STAT tests in emergency or critical care settings (troponin in chest pain, blood gases in respiratory failure, lactate in suspected sepsis), even delays of 30 to 60 minutes can influence clinical decisions, patient routing, and outcomes. The Joint Commission continues to identify diagnostic delays as a persistent contributor to patient safety events.

For routine testing, the implications are less acute but no less real. Prolonged TAT increases the likelihood of repeated sample collection, delayed treatment initiation, extended hospital stays, and clinical team dissatisfaction, all of which carry both clinical and operational costs.

The Three Types of TAT You Need to Track

One of the most common mistakes in TAT management is treating it as a single, monolithic metric. In practice, TAT consists of three distinct phases. Measuring only one of them gives an incomplete and often misleading picture.

Total TAT spans from sample collection to result available to the clinician. This is the metric that matters most to clinical teams, and the hardest to measure accurately, because it requires timestamps across systems that often do not communicate with each other.

Intra-laboratory TAT measures the interval from sample receipt at the laboratory to result reporting. This is the metric most laboratories track, because it falls entirely within their operational control and can be captured through the LIS. It is useful, but it represents only part of the story.

Pre-analytical TAT covers the time between sample collection and arrival at the laboratory: collection, labelling, transport, and reception handling. It is frequently the longest phase of the total TAT, and the least visible.

The distinction matters: a laboratory that optimises its intra-laboratory processes and achieves excellent intra-lab TAT may still be delivering results hours after collection, simply because the pre-analytical phase was never measured or addressed.

How to Measure TAT Correctly

Accurate TAT measurement depends on consistent, well-defined timestamps captured at each phase transition. The most critical intervals to record are:

• Order placed — when the test request is created in the system
• Collection time — when the sample is taken from the patient
• Transport dispatched — when the sample leaves the collection point
• Laboratory receipt — when the sample is scanned in at the lab (start of intra-lab TAT)
• Pre-analytical processing complete — centrifugation, aliquoting, sorting
• Analysis start — when the sample is loaded on the analyser
• Result available — validated and released to the clinician

The most frequent measurement error is using the order timestamp as the TAT start point. This artificially inflates apparent TAT without revealing where delays actually occur. Equally important: never mix STAT and routine samples in a single TAT calculation. A laboratory reporting an average TAT of 45 minutes may be concealing STAT results that routinely take 90 minutes and routine results delivered in 30, with both problems invisible in the aggregate.

CLSI EP23 provides the methodological framework for TAT measurement and is the standard reference for laboratories establishing or auditing their TAT tracking programmes.

TAT Benchmarks: What Does Good Performance Look Like?

TAT expectations vary considerably by test type, urgency class, and clinical setting. The following benchmarks reflect current guidance from CAP Q-PROBES studies and published laboratory quality literature.

Sources: CAP Q-PROBES studies; CLSI EP23. Targets should always be agreed locally with clinical teams; these figures serve as reference points, not mandates.

Where TAT Is Actually Lost: The Pre-Analytical Blind Spot

Here is where most TAT improvement programmes stall: the assumption that the problem lives inside the laboratory.

Research in laboratory medicine consistently shows that 60–70% of total laboratory TAT is consumed by pre-analytical processes, the events that occur before a sample reaches the analyser. This includes collection, transport, reception, and initial processing. The analytical phase itself accounts for a relatively small fraction of total elapsed time.

Yet the majority of laboratory improvement initiatives focus almost exclusively on the intra-laboratory phase, the part that is already measured and often already reasonably well optimised. Pre-analytical processes are difficult to manage for a structural reason: they frequently lie outside the direct control of the laboratory. Transport is handled by couriers or pneumatic systems. Collection happens at wards, outpatient clinics, or remote sites. The laboratory may not know a sample exists until it physically arrives.

The practical implication is straightforward: improving TAT requires extending measurement and visibility into the pre-analytical phase, not just further optimising what happens inside the lab.

How to Improve Laboratory TAT: A Practical Framework

TAT improvement is not a single project. It is a continuous process that depends on data, visibility, and a structured approach to identifying and eliminating bottlenecks.

1. 1
   Map your actual TAT before changing anythingCollect timestamp data across all phases for a representative period, typically two to four weeks. The goal is to understand where time is actually going, not where you think it is going. Most laboratories find significant differences between estimated and measured TAT, particularly in the pre-analytical phase.
2. 2
   Separate STAT from routine and treat them as different workflowsSTAT and routine samples have different clinical urgency, different volume patterns, and different acceptable TAT thresholds. Tracking them together produces averages that optimise for neither. Define separate targets, escalation thresholds, and review processes for each category.
3. 3
   Eliminate visibility gaps in transportSamples dispatched from remote collection sites may sit uncollected, take indirect routes, or arrive at the lab with no prior notification. Implementing real-time tracking on transport (whether through courier apps, pneumatic tube monitoring, or barcode scan checkpoints) converts transport from a black box into a managed workflow stage. The S4DX Courier App is designed for exactly this: GPS tracking, pick-up timestamps, and delivery monitoring per route in real time. For temperature- and vibration-sensitive specimens, the S4DX SmartTube Datalogger records environmental conditions continuously throughout transit, providing an objective audit trail alongside the logistics data.
4. 4
   Automate reception checkpointsAutomated barcode scanning on receipt eliminates manual transcription, creates accurate timestamps, and immediately notifies downstream processing teams. For high-volume laboratories, even small reductions in reception handling time per sample compound significantly across a day.
5. 5
   Implement real-time alerts for outlier samplesA STAT sample sitting at a collection point for 45 minutes should trigger an escalation before it becomes a problem, not after the clinician calls. Alert thresholds tied to expected TAT phases allow pre-analytical delays to be addressed in real time rather than captured only in retrospective reporting.
6. 6
   Close the loop with data: review, adjust, repeatWeekly or monthly review of TAT data, segmented by phase, test type, collection site, and courier, surfaces patterns that are invisible in daily operations. The question is not "what was our average TAT last month" but "which collection sites or transport routes are consistently driving outliers."

The Role of Sample Tracking in TAT Reduction

The practical thread running through every step of the framework above is visibility: the ability to know, in real time, where a sample is, what stage it is at, and whether it is on track to meet its TAT target.

End-to-end sample tracking provides exactly this. When every phase of the pre-analytical workflow is timestamped and visible, from collection through transport to reception, the laboratory has the data it needs to:

• Identify which phase of the workflow is responsible for TAT overruns
• Determine whether transport delays are systemic or isolated to specific routes or collection sites
• Trigger real-time interventions before a STAT sample misses its target
• Demonstrate continuous improvement with objective data during accreditation reviews (ISO 15189:2022, Section 7)

Without end-to-end visibility, TAT improvement becomes a process of managing averages and reacting to exceptions. With it, the pre-analytical phase becomes as measurable and manageable as the intra-laboratory phase.

This is consistent with the broader evidence on the cost of pre-analytical errors: the majority of quality failures in laboratory medicine originate upstream, and addressing them systematically requires data that starts well before the sample arrives at the laboratory. Connecting sample identification with real-time tracking across all phases is what makes that data actionable.

The S4DX platform is built around this principle. The S4DX Courier App and S4DX SmartTube Datalogger cover the transport leg; the Gateway automates sample registration at laboratory entry; and S4DX WebServices consolidates every timestamp into a TAT dashboard the team can act on. Each module feeds the same audit trail, giving laboratories the evidence base to identify bottlenecks, defend process decisions, and demonstrate compliance under ISO 15189.

Key Takeaways

• TAT is a multi-phase metric. Measuring only intra-laboratory TAT gives an incomplete picture; total TAT and pre-analytical TAT must be tracked separately.
• 60–70% of total laboratory TAT is consumed by pre-analytical processes, before the sample reaches the analyser.
• Accurate measurement depends on consistent timestamps at each phase transition, with STAT and routine tracked as separate workflows.
• Most laboratories cannot improve pre-analytical TAT because they have no real-time visibility into it.
• Sustained improvement requires a structured framework: map, segment, instrument, alert, and review.
• End-to-end sample tracking is not an optimisation for labs that have already solved TAT; it is the prerequisite for solving it.